Ernexa Therapeutics Inc. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-K405
10-Q
10-Q/A
15-12G
25
3
3/A
4
4/A
424B3
424B5
425
5
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DEFS14A
DRS
EFFECT
NT 10-K
NT 10-K/A
NT 10-Q
POS AM
PRE 14A
PRES14A
REGDEX
RW
S-1
S-1/A
S-3
S-3/A
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| S-3/A | S-3/A | 0001493152-26-012387 | Mar 24, 2026 | — |
| 8-K | 8-K | 0001493152-26-011922 | Mar 20, 2026 | Mar 18, 2026 |
| S-3 | S-3 | 0001493152-26-010128 | Mar 16, 2026 | — |
| 10-K | 10-K | 0001493152-26-010102 | Mar 13, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001493152-26-008182 | Feb 26, 2026 | — |
| SCHEDULE 13D/A | — | 0001104659-26-016685 | Feb 17, 2026 | — |
| 4 | OWNERSHIP DOCUMENT | 0001104659-26-016680 | Feb 17, 2026 | Feb 10, 2026 |
| 8-K | 8-K | 0001493152-26-006227 | Feb 11, 2026 | Feb 6, 2026 |
| 424B5 | 424B5 | 0001493152-26-005898 | Feb 10, 2026 | — |
| EFFECT | — | 9999999995-26-000458 | Feb 5, 2026 | — |
| CERT | — | 0001354457-26-000143 | Feb 5, 2026 | — |
| 8-A12B | 8-A12B | 0001493152-26-005226 | Feb 5, 2026 | — |
| S-1/A | S-1/A | 0001493152-26-005215 | Feb 5, 2026 | — |
| S-1/A | S-1/A | 0001493152-26-004987 | Feb 4, 2026 | — |
| S-1 | S-1 | 0001493152-26-004809 | Feb 3, 2026 | — |
| SCHEDULE 13G/A | — | 0001193125-25-326739 | Dec 19, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-121683 | Dec 16, 2025 | — |
| 8-K | 8-K | 0001493152-25-027167 | Dec 11, 2025 | — |
| 10-Q | 10-Q | 0001493152-25-021287 | Nov 7, 2025 | Sep 30, 2025 |
| DRS | — | 0001493152-25-018969 | Oct 23, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-079777 | Aug 18, 2025 | — |
| 10-Q | 10-Q | 0001493152-25-011910 | Aug 13, 2025 | Jun 30, 2025 |
| 4 | — | 0001641172-25-018063 | Jul 7, 2025 | Jun 21, 2025 |
| 8-K | 8-K | 0001641172-25-018009 | Jul 7, 2025 | Jun 30, 2025 |
| EFFECT | — | 9999999995-25-001964 | Jun 18, 2025 | — |
| 424B3 | 424B3 | 0001641172-25-015608 | Jun 18, 2025 | — |
| CORRESP | — | 0001641172-25-015240 | Jun 16, 2025 | — |
| UPLOAD | — | 0000000000-25-006284 | Jun 16, 2025 | — |
| 8-K | 8-K | 0001641172-25-014877 | Jun 12, 2025 | — |
| SCHEDULE 13D/A | — | 0001104659-25-058646 | Jun 11, 2025 | — |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-058644 | Jun 11, 2025 | Jun 9, 2025 |
| S-8 | S-8 | 0001641172-25-014724 | Jun 11, 2025 | — |
| S-3 | S-3 | 0001641172-25-014720 | Jun 11, 2025 | — |
| 8-K | 8-K | 0001641172-25-014318 | Jun 9, 2025 | — |
| 8-K | 8-K | 0001641172-25-013249 | Jun 2, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-073071 | May 15, 2025 | — |
| SCHEDULE 13G | — | 0001104659-25-049542 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-048689 | May 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-071206 | May 14, 2025 | — |
| 10-Q | 10-Q | 0001641172-25-009044 | May 7, 2025 | Mar 31, 2025 |
| 4/A | OWNERSHIP DOCUMENT | 0001104659-25-045416 | May 7, 2025 | Sep 24, 2024 |
| EFFECT | — | 9999999995-25-001282 | Apr 29, 2025 | — |
| 424B3 | PROSPECTUS | 0001641172-25-006667 | Apr 29, 2025 | — |
| CORRESP | — | 0001641172-25-006249 | Apr 25, 2025 | — |
| UPLOAD | — | 0000000000-25-004418 | Apr 25, 2025 | — |
| S-3 | — | 0001641172-25-005057 | Apr 16, 2025 | — |
| ARS | — | 0001641172-25-004594 | Apr 14, 2025 | Dec 31, 2024 |
| DEF 14A | — | 0001641172-25-004585 | Apr 14, 2025 | Dec 31, 2024 |
| D | — | 0001641172-25-003828 | Apr 11, 2025 | — |
| SCHEDULE 13D/A | — | 0001104659-25-032062 | Apr 4, 2025 | — |